<DOC>
	<DOCNO>NCT03067441</DOCNO>
	<brief_summary>The purpose study see bempedoic acid ( ETC-1002 ) safe well-tolerated patient high cardiovascular risk elevate LDL cholesterol adequately control current therapy .</brief_summary>
	<brief_title>Assessment Long-Term Safety Efficacy Bempedoic Acid ( CLEAR Harmony OLE )</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Successfully complete CLEAR Harmony ( 1002040 ) parent study Experienced treatmentrelated SAE lead study drug discontinuation CLEAR Harmony ( 1002040 ) parent study . Medical condition require lipid measurement and/or adjustment background lipidregulating therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hyperlipidemia</keyword>
	<keyword>cholesterol</keyword>
	<keyword>heterozygous familial hypercholesterolemia</keyword>
	<keyword>atherosclerotic cardiovascular disease</keyword>
	<keyword>ASCVD</keyword>
	<keyword>HeFH</keyword>
	<keyword>LDL</keyword>
</DOC>